2021-01-11,ObsEva Provides Update on Yselty® (Linzagolix) Clinical Development Program
2021-01-07,"ObsEva SA to Participate in JP Morgan Virtual Healthcare Conference January 11 - 14, 2021"
2021-01-04,ObsEva appoints David Renas as Chief Financial Officer
2020-12-10,ObsEva Announces Additional Phase 3 PRIMROSE 1 and 2 Study Results Confirming Sustained Efficacy and Continued Safety of linzagolix in the Treatment of Uterine Fibroids
2020-12-02,Is ObsEva SA (OBSV) A Good Stock To Buy Now?
2020-12-01,"ObsEva SA to present at The International Society of Gynecological Endocrinology 19th World Congress  virtual edition, December 2-5, 2020"
2020-11-30,ObsEva (OBSV) Catches Eye: Stock Jumps 5.1%
2020-11-24,"The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia"
2020-11-24,ObsEva SA Submits Marketing Authorization Application to the European Medicines Agency for YSELTY® (linzagolix) for the Treatment of Women with Uterine Fibroids
2020-11-16,What Type Of Shareholders Make Up ObsEva SA's (NASDAQ:OBSV) Share Registry?
2020-11-16,ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor
2020-11-13,"ObsEva SA to present at Jefferies Virtual London Healthcare Conference, November 17  19, 2020"
2020-11-09,ObsEva appoints Brian OCallaghan as Chief Executive Officer
2020-11-05,ObsEva Announces Third Quarter 2020 Financial Results and Business Update
2020-11-02,"ObsEva SA hosts live symposium and presents oral communication at the SEUD Online Week November 3 - 6, 2020"
2020-10-22,ObsEva SA Presented Two Late-Breaking Posters at the ASRM 2020 Virtual Scientific Congress October 17-21
2020-10-20,ObsEva SA Presented Nolasiban Poster at the ASRM 2020 Virtual Scientific Congress October 17-21
2020-10-06,"These 2 Penny Stocks Could Quadruple (Or More), Says H.C. Wainwright"
2020-09-08,"ObsEva SA to present at the H.C Wainwright 22nd Annual Global Investment  Virtual Conference, September 14-16, 2020"
2020-09-03,ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement  Priced At-The-Market of Common Shares and 15-Month Purchase Warrants for  Potential Additional Gross Proceeds of $23.9 Million
2020-08-07,"ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11  12, 2020"
2020-08-06,ObsEva Announces Second Quarter 2020 Financial Results and Business Update
2020-07-23,Edited Transcript of OBSV.OQ earnings conference call or presentation 7-Aug-19 12:00pm GMT
2020-07-15,"ObsEva SA Awarded Clinical Science Award for Oral Presentation at ESHRE Virtual 36th Annual Meeting, July 2020"
2020-07-06,"The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus"
2020-07-06,"ObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids"
2020-07-03,"ObsEva SA to present at ESHRE Virtual 36th Annual Meeting, July 5-8, 2020"
2020-07-01,ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
2020-06-29,"ObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 Trials Evaluating Linzagolix in Women with Uterine Fibroids"
2020-06-21,Is ObsEva SA (OBSV) A Good Stock To Buy?
2020-06-09,"ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020"
2020-06-04,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic"
2020-06-04,ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
2020-05-29,"ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020"
2020-05-11,New Forecasts: Here's What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)
2020-05-08,ObsEva Annual General Meeting 2020
2020-05-08,Here's What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter Results
2020-05-07,"These 3 Biotech Stocks Have Massive Upside Potential, Says Wedbush"
2020-05-05,ObsEva Announces First Quarter 2020 Financial Results and Business Update
2020-04-23,How ObsEva (OBSV) Stock Stands Out in a Strong Industry
2020-04-22,ObsEva Announces Publication of Abstracts from Phase 2b EDELWEISS Trial of Linzagolix in Endometriosis
2020-04-21,Imagine Owning ObsEva (NASDAQ:OBSV) And Trying To Stomach The 85% Share Price Drop
2020-04-14,ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
2020-04-06,ObsEva SA Announces New Interim Chief Financial Officer
2020-03-27,ObsEva SA: New Date Announcement for AGM
2020-03-23,ObsEva Provides Update Related to COVID-19 Pandemic
2020-03-05,ObsEva SA Link to Annual Report 2019
2020-03-05,ObsEva Announces Year End 2019 Financial Results and Business Update
2020-02-27,"ObsEva SA to Hold Year End 2019 Financial Results and Business Update Conference Call on March 5, 2020"
2020-02-18,ObsEva SA to present at the SVB LEERINK 9th Annual Global Healthcare Conference February 26th 2020
2020-01-22,Health Check: How Prudently Does ObsEva (NASDAQ:OBSV) Use Debt?
2020-01-16,Analysts Suggest Picking Up These 2 Falling Knives
2020-01-15,ObsEva to Outline Corporate Plans For 2020 and Beyond at JP Morgan Healthcare Conference in San Francisco
2020-01-13,ObsEva and Yuyuan BioScience Technology Announce Sublicense Agreement to Develop and Commercialize Nolasiban in the People's Republic of China
2020-01-09,Catabasis (CATB) Partners with UK-Based Charity for DMD Study
2020-01-07,"ObsEva SA to Participate in in JP Morgan Healthcare Conference January 13-16, 2020"
2019-12-16,ObsEva SA (OBSV) Is Burning These Hedge Funds
2019-12-12,3 Biotech Stocks That Offer the Highest Upside on Wall Street
2019-12-09,ObsEva's Menstrual Bleeding Drug Produces 'Best-In-Class' Response In Late-Stage Study
2019-12-09,ObsEva shares rise on new data about fibroid treatment
2019-12-09,ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
2019-12-06,"ObsEva SA to Hold Conference Call to Discuss PRIMROSE 2 Trial Results on December 9, 2019"
2019-12-03,ObsEva Sees Hammer Chart Pattern: Time to Buy?
2019-11-18,Edited Transcript of OBSV.O earnings conference call or presentation 7-Nov-19 1:00pm GMT
2019-11-15,ObsEva Enters Oversold Territory
2019-11-08,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut"
2019-11-07,"ObsEva SA (OBSV) Reports Q3 Loss, Misses Revenue Estimates"
2019-11-07,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs"
2019-11-07,ObsEva Announces Third Quarter 2019 Financial Results
2019-11-07,Obseva Announces That Nolasiban Implant 4 Study Did Not Meet Primary Endpoint
2019-11-06,"ObsEva SA to Hold Conference Call to Discuss IMPLANT 4 Trial Results and Third Quarter 2019 Financial and Business Update on November 7, 2019"
2019-11-06,ObsEva SA to Participate in Upcoming Investor Conferences
2019-11-04,"ObsEva SA to Hold Third Quarter 2019 Financial Results and Business Update Call on November 11, 2019"
2019-10-31,ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical Trial (IMPLANT 3) of Nolasiban in Women Undergoing Embryo Transfer Following IVF
2019-10-14,Do Directors Own ObsEva SA (NASDAQ:OBSV) Shares?
2019-10-11,ObsEva SA to Present Model-Based Analysis Supporting Clinical Use of Linzagolix at Doses Not Requiring Hormonal Add back Therapy
2019-10-09,"ObsEva SA to Present New Clinical Data on its Lead Compounds Nolasiban and Linzagolix at the 75th Annual ASRM Meeting in Philadelphia, PA"
2019-09-27,"ObsEva SA to Participate in Cantor Global Healthcare Conference October 2-4, 2019"
2019-09-11,ObsEva announces new composition of its Executive Committee
2019-09-03,"ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of Action, Supporting Its Potential to Increase Live Birth Rate Following Embryo Transfer in IVF"
2019-08-30,ObsEva SA to Participate in Upcoming Investor Conferences
2019-08-29,Did Changing Sentiment Drive ObsEva's (NASDAQ:OBSV) Share Price Down By 24%?
2019-08-15,ObsEva SA (OBSV) Q2 2019 Earnings Call Transcript
2019-08-09,"ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13-14, 2019"
2019-08-07,"ObsEva SA (OBSV) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-07,ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC
2019-08-07,ObsEva Reports Second Quarter 2019 Financial Results
2019-08-05,"ObsEva SA to Hold Second Quarter 2019 Financial Results and Business Update Call on August 7, 2019"
2019-07-26,ObsEva SA Reports Positive Feedback from Independent Data Monitoring Committee for PROLONG Part B with OBE022
2019-07-18,ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
2019-07-17,"ObsEva Hosts KOL Meeting on IVF Trends, Unmet Need and Market Potential of Nolasiban"
2019-07-12,"ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) July 17, 2019 in New York City"
2019-07-08,ObsEva Ends Recruitment in Second Uterine Fibroids Study
2019-07-08,ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 1 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids
2019-07-01,ObsEva appoints industry expert as Chief Medical Officer to further advance its Phase 3 clinical programs
2019-06-28,Here is What Hedge Funds Think About ObsEva SA (OBSV)
2019-06-21,ObsEva SA to Present Nolasiban and Linzagolix Clinical Data at the ESHRE Annual Meeting June 23-26 in Vienna
2019-06-19,ObsEva Progressing Toward U.S. Phase 3 Trial for Nolasiban in IVF Following Recent FDA Meeting
2019-06-13,Wedbush: 5 Stocks On Our Best Ideas List
2019-06-07,Edited Transcript of OBSV.O earnings conference call or presentation 9-May-19 12:00pm GMT
